Executive Summary
Summary Biohit Oyj (Biohit) is a biotechnology company that offers research and early diagnosis processing products. The company's products comprise acetaldehyde binding products, diagnostic tests, dysbiosis test, microplate readers and washers, monoclonal antibodies, and pipettes. It targets therapeutic areas such as gastric cancer, gastroesophageal reflux disease and colorectal cancer, among others. Biohit provides analyses of non-alcoholic and alcoholic beverages and carcinogenic acetaldehyde in foodstuff. The company promotes evaluation and adoption of Biohit's diagnostic tests and analysing systems. It also offers tests for the diagnosis of lactose intolerance and helicobacter pylori infection. The company operates in Finland, Italy and the UK. Biohit is headquartered in Helsinki, Finland. Biohit Oyj (BIOBV)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions. GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research. Scope - Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. - Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. - Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. - Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. - Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector. - Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios. - Business Description-A brief description of the company's operations. - Key Employees-A list of the key executives of the company. - Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company. - Key Competitors-A list of the key competitors of the company. - Key Recent Developments-A brief on recent news about the company. Reasons to buy Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements - The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period. Understand the company's business segments' expansion / divestiture strategy - The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy. Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios. Equip yourself with detailed information about the company's operations to identify potential customers and suppliers. - The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors. Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events. Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs. Note*: Some sections may be missing if data is unavailable for the company.
Read More
Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
ankur [@] kenresearch.com
+91-9015378249
Table of Contents Table of Contents 3 List of Tables 4 List of Figures 4 Biohit Oyj, Medical Equipment, Deals By Year, 2012 to YTD 2018 5 Biohit Oyj, Medical Equipment Deals By Type, 2012 to YTD 2018 6 Biohit Oyj, Medical Equipment, Deals By Region, 2012 to YTD 2018 7 Biohit Oyj, Medical Equipment, Deals By Market, 2012 to YTD 2018 8 Biohit Oyj, Medical Equipment, Deals Summary, 2012 to YTD 2018 9 Biohit Oyj, Medical Equipment, Deal Details 10 Asset Purchase 10 Biohit Acquires Rights To UFT300 Test From Advanced Biomedical Systems For USD 0.5 Million 10 Partnerships 11 Biohit HealthCare (Hefei) Enters into Licensing Agreement with Biohit 11 Biohit Enters Into Licensing Agreement With Randox For GastroPanel Test 12 Biohit Enters into Distribution Agreement with Pooyandegan Pezeshki Pardis 13 Biohit and Onsite Diagnostic Labs Enter into Distribution Agreement 14 Biohit Enters into Distribution Agreement with Genetic Analysis 15 Biohit Enters Into Distribution Agreement With Dynex Technologies 16 Biohit Forms Joint Venture with Anhui Wisdom-Win Investment 17 Ferring Pharma Enters Into Distribution Agreement With Biohit Healthcare For PreventID CalScreen 18 Biohit Enters Into Distribution Agreement With IBL International For GastroPanel 19 Biohit Enters Into Distribution Agreement With Hefei Medicine For GastroPanel Test 20 Biohit Enters Into Distribution Agreement With Fisher Scientific For Diagnostic Products 21 Biohit Enters Into Distribution Agreement With Euro-Diagnostica For GastroPanel 22 Acquisition 23 Biohit Acquires 18% Stake in Genetic Analysis 23 Biohit Completes Acquisition of Euroclone Gastro from Euroclone for USD1.48 Million 24 Biohit Oyj-Key Competitors 25 Biohit Oyj-Key Employees 26 Biohit Oyj-Locations And Subsidiaries 27 Head Office 27 Other Locations & Subsidiaries 27 Joint Venture 27 Recent Developments 28 Financial Announcements 28 Aug 22, 2018: Biohit Group half year financial report 2018 28 Feb 28, 2018: Biohit Group Financial Statement Release 2017 37 Aug 17, 2017: Biohit Group Half Year Financial Report 2017 44 Feb 20, 2017: Biohit Group Financial Statement Release 2016 49 Corporate Communications 53 Jul 30, 2018: Biohit Oyj: Management changes 53 Feb 20, 2018: Changes to Biohit Oyj's Management Team 54 May 04, 2017: Lea Paloheimo appointed Biohit Oyj's R&D and production director 55 Appendix 56 Methodology 56 About GlobalData 56 Contact Us 56 Disclaimer 56
List of Tables Biohit Oyj, Medical Equipment, Key Facts, 2017 2 Biohit Oyj, Medical Equipment, Deals Summary, 2012 to YTD 2018 2 Biohit Oyj, Medical Equipment, Deals By Year, 2012 to YTD 2018 5 Biohit Oyj, Medical Equipment Deals By Type, 2012 to YTD 2018 6 Biohit Oyj, Medical Equipment, Deals By Region, 2012 to YTD 2018 7 Biohit Oyj, Deals By Market, 2012 to YTD 2018 8 Biohit Oyj, Medical Equipment, Deals Summary, 2012 to YTD 2018 9 Biohit Acquires Rights To UFT300 Test From Advanced Biomedical Systems For USD 0.5 Million 10 Biohit HealthCare (Hefei) Enters into Licensing Agreement with Biohit 11 Biohit Enters Into Licensing Agreement With Randox For GastroPanel Test 12 Biohit Enters into Distribution Agreement with Pooyandegan Pezeshki Pardis 13 Biohit and Onsite Diagnostic Labs Enter into Distribution Agreement 14 Biohit Enters into Distribution Agreement with Genetic Analysis 15 Biohit Enters Into Distribution Agreement With Dynex Technologies 16 Biohit Forms Joint Venture with Anhui Wisdom-Win Investment 17 Ferring Pharma Enters Into Distribution Agreement With Biohit Healthcare For PreventID CalScreen 18 Biohit Enters Into Distribution Agreement With IBL International For GastroPanel 19 Biohit Enters Into Distribution Agreement With Hefei Medicine For GastroPanel Test 20 Biohit Enters Into Distribution Agreement With Fisher Scientific For Diagnostic Products 21 Biohit Enters Into Distribution Agreement With Euro-Diagnostica For GastroPanel 22 Biohit Acquires 18% Stake in Genetic Analysis 23 Biohit Completes Acquisition of Euroclone Gastro from Euroclone for USD1.48 Million 24 Biohit Oyj, Key Competitors 25 Biohit Oyj, Key Employees 26 Biohit Oyj, Subsidiaries 27 Biohit Oyj, Joint Venture 27
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
Biohit Oyj, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
|
Agriculture and Animal Care
Automotive, Transportation and Warehousing
Banking Financial Services and Insurance
Consumer Products and Retail
Defense and Security
Education and Recruitment
Energy and Utilities
Food, Beverage and Tobacco
Healthcare
Manufacturing and Construction
Media and Entertainment
Metal, Mining and Chemicals
Public Sector and Administration
Technology and Telecom
